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hIAPP is sufficient and 
necessary to develop T2DM 
Human islet amyloid polypeptide (hIAPP) is one of the
major hormones produced by pancreatic β-cells and is
involved in type-II diabetes mellitus (T2DM) pathogenesis.
T2DM is a complex syndrome characterized by impaired
insulin secretion and action. The loss of pancreatic β-cell
mass is accompanied by the accumulation of amyloid
deposits of hIAPP. The relationship between amyloidosis,
cell-death and disease progression is extremely complex [1].
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Future approaches: A personal contribution
Conclusions Key references
• Although the molecular mechanisms are unclear, hIAPP plays a decisive role
in T2DM, this role may vary depending on the circumstances of the disease.
• Therapies targeting IAPP are a promising possibility to prevent T2DM or
stop its progression. Removal of hIAPP from plasma is an unexplored and
interesting approach.
Which therapeutic possibilities are most promising?
Can we remove hIAPP from plasma?
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hIAPP participates in T2DM progression 
hIAPP contributes to T2DM
in a positive feedback.
Figure adapted from 
Asthana et al. (2018).
hIAPP reduces insulin secretion in β-cells
↓ Reduced insulin secretion ↓
hIAPP causes β-cell death
• Based on recent kinetic studies, I suggest that
membrane interaction occurs in distinct stages.
• Small-molecules can prevent β-cell death acting
on different steps of this cascade.
hIAPP fibrillation is enhanced in membranes
in contrast with rodent IAPP (rIAPP) [2].
hIAPP associates with and destroys β-cell membranes
• In Alzheimer, circulating
amyloid (Aβ) associates
with serum albumin.
• Plasmapheresis replaces
albumin bound to Aβ
with synthetic albumin.
• I propose that T2DM
may be treated using the
same strategy since
hIAPP binds to albumin.
Vaccination of transgenic mice shows a
nearly complete abolition of T2DM [3].
2  Vaccination
1  Small-molecule inhibitors
Resveratrol, 4-O-PR, 4-DMPR, ADM-116, EGCG 
Integrative model for membrane disruption
[4]
Cell viability is restored using high-affinity
antibodies targeting hIAPP.
